EcoDrugPlus

Ensembl ID : ENSOSIG00000008165
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSOSIG00000012804
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSOSIG00000013234
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOSIG00000010303
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSOSIG00000018037
Gene Symbol: -
Cross references: -
521 Possible Orthologues:

Ensembl ID : ENSOSIG00000017072
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOSIG00000023583
Gene Symbol: SIGMAR1
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSOSIG00000009050
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOSIG00000017061
Gene Symbol: RPS4X
1 Cross references
494 Possible Orthologues:

Ensembl ID : ENSOSIG00000009670
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSOSIG00000016991
Gene Symbol: -
Cross references: -
520 Possible Orthologues:

Ensembl ID : ENSOSIG00000016985
Gene Symbol: -
Cross references: -
521 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).